OTCMKTS:CANN

General Cannabis Competitors

$0.89
0.00 (0.00 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.88
Now: $0.89
$0.92
50-Day Range
$0.87
MA: $1.04
$1.47
52-Week Range
$0.26
Now: $0.89
$2.08
Volume95,836 shs
Average Volume564,945 shs
Market Capitalization$55.31 million
P/E RatioN/A
Dividend YieldN/A
Beta0.95

Competitors

General Cannabis (OTCMKTS:CANN) Vs. IIPR, GRWG, XXII, KSHB, NSAV, and TRTC

Should you be buying CANN stock or one of its competitors? Companies in the sub-industry of "cannabis" are considered alternatives and competitors to General Cannabis, including Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), NSAV (NSAV), and Terra Tech (TRTC).

Innovative Industrial Properties (NYSE:IIPR) and General Cannabis (OTCMKTS:CANN) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Analyst Recommendations

This is a breakdown of current ratings for Innovative Industrial Properties and General Cannabis, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Innovative Industrial Properties02502.71
General Cannabis0000N/A

Innovative Industrial Properties presently has a consensus target price of $192.4286, indicating a potential upside of 1.82%. Given Innovative Industrial Properties' higher probable upside, equities analysts plainly believe Innovative Industrial Properties is more favorable than General Cannabis.

Profitability

This table compares Innovative Industrial Properties and General Cannabis' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Innovative Industrial Properties55.71%6.05%4.82%
General Cannabis-167.65%N/A-171.06%

Valuation & Earnings

This table compares Innovative Industrial Properties and General Cannabis' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Industrial Properties$44.67 million101.23$23.48 million$3.2757.80
General Cannabis$3.67 million15.07$-15,480,000.00N/AN/A

Innovative Industrial Properties has higher revenue and earnings than General Cannabis.

Institutional & Insider Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by company insiders. Comparatively, 38.0% of General Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Innovative Industrial Properties has a beta of 1.52, suggesting that its stock price is 52% more volatile than the S&P 500. Comparatively, General Cannabis has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

Summary

Innovative Industrial Properties beats General Cannabis on 10 of the 11 factors compared between the two stocks.

General Cannabis (OTCMKTS:CANN) and GrowGeneration (NASDAQ:GRWG) are both business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Earnings and Valuation

This table compares General Cannabis and GrowGeneration's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
General Cannabis$3.67 million15.07$-15,480,000.00N/AN/A
GrowGeneration$79 million39.97$1.88 million$0.10540.20

GrowGeneration has higher revenue and earnings than General Cannabis.

Insider and Institutional Ownership

51.3% of GrowGeneration shares are held by institutional investors. 38.0% of General Cannabis shares are held by company insiders. Comparatively, 13.6% of GrowGeneration shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations for General Cannabis and GrowGeneration, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
General Cannabis0000N/A
GrowGeneration03502.63

GrowGeneration has a consensus target price of $49.5714, suggesting a potential downside of 8.24%. Given GrowGeneration's higher possible upside, analysts plainly believe GrowGeneration is more favorable than General Cannabis.

Profitability

This table compares General Cannabis and GrowGeneration's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
General Cannabis-167.65%N/A-171.06%
GrowGeneration2.14%4.68%3.53%

Risk & Volatility

General Cannabis has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Comparatively, GrowGeneration has a beta of 3.09, indicating that its share price is 209% more volatile than the S&P 500.

Summary

GrowGeneration beats General Cannabis on 10 of the 11 factors compared between the two stocks.

22nd Century Group (NYSEAMERICAN:XXII) and General Cannabis (OTCMKTS:CANN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for 22nd Century Group and General Cannabis, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
22nd Century Group00103.00
General Cannabis0000N/A

Earnings & Valuation

This table compares 22nd Century Group and General Cannabis' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
22nd Century GroupN/AN/AN/AN/AN/A
General Cannabis$3.67 million15.07$-15,480,000.00N/AN/A

22nd Century Group has higher earnings, but lower revenue than General Cannabis.

Profitability

This table compares 22nd Century Group and General Cannabis' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
22nd Century GroupN/AN/AN/A
General Cannabis-167.65%N/A-171.06%

Summary

22nd Century Group beats General Cannabis on 3 of the 4 factors compared between the two stocks.

General Cannabis (OTCMKTS:CANN) and KushCo (OTCMKTS:KSHB) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Risk and Volatility

General Cannabis has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, KushCo has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for General Cannabis and KushCo, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
General Cannabis0000N/A
KushCo01302.75

KushCo has a consensus price target of $1.8750, suggesting a potential upside of 45.35%. Given KushCo's higher probable upside, analysts clearly believe KushCo is more favorable than General Cannabis.

Insider and Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 38.0% of General Cannabis shares are owned by company insiders. Comparatively, 17.3% of KushCo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares General Cannabis and KushCo's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
General Cannabis$3.67 million15.07$-15,480,000.00N/AN/A
KushCo$113.84 million1.80$-77,660,000.00($0.68)-1.90

General Cannabis has higher earnings, but lower revenue than KushCo.

Profitability

This table compares General Cannabis and KushCo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
General Cannabis-167.65%N/A-171.06%
KushCo-65.89%-47.95%-31.39%

Summary

KushCo beats General Cannabis on 7 of the 11 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and General Cannabis (OTCMKTS:CANN) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Analyst Recommendations

This is a summary of recent ratings and price targets for NSAV and General Cannabis, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
NSAV0000N/A
General Cannabis0000N/A

Earnings & Valuation

This table compares NSAV and General Cannabis' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NSAVN/AN/AN/AN/AN/A
General Cannabis$3.67 million15.07$-15,480,000.00N/AN/A

NSAV has higher earnings, but lower revenue than General Cannabis.

Volatility & Risk

NSAV has a beta of 3.85, indicating that its stock price is 285% more volatile than the S&P 500. Comparatively, General Cannabis has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.

Profitability

This table compares NSAV and General Cannabis' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
NSAVN/AN/AN/A
General Cannabis-167.65%N/A-171.06%

Summary

NSAV beats General Cannabis on 3 of the 4 factors compared between the two stocks.

Terra Tech (OTCMKTS:TRTC) and General Cannabis (OTCMKTS:CANN) are both small-cap industrial products companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

Risk and Volatility

Terra Tech has a beta of 2.4, indicating that its share price is 140% more volatile than the S&P 500. Comparatively, General Cannabis has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500.

Earnings & Valuation

This table compares Terra Tech and General Cannabis' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Terra Tech$28.05 million2.25$-46,930,000.00N/AN/A
General Cannabis$3.67 million15.07$-15,480,000.00N/AN/A

General Cannabis has lower revenue, but higher earnings than Terra Tech.

Analyst Ratings

This is a summary of recent ratings and target prices for Terra Tech and General Cannabis, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Terra Tech0000N/A
General Cannabis0000N/A

Insider & Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by insiders. Comparatively, 38.0% of General Cannabis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Terra Tech and General Cannabis' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Terra Tech-261.88%-110.38%-62.41%
General Cannabis-167.65%N/A-171.06%

Summary

General Cannabis beats Terra Tech on 5 of the 9 factors compared between the two stocks.


General Cannabis Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Innovative Industrial Properties logo
IIPR
Innovative Industrial Properties
1.8$188.99flat$4.52 billion$44.67 million61.16
GrowGeneration logo
GRWG
GrowGeneration
1.7$54.02flat$3.16 billion$79 million1,080.62Analyst Revision
22nd Century Group logo
XXII
22nd Century Group
0.9$3.61flat$550.16 millionN/A0.00
KushCo logo
KSHB
KushCo
1.3$1.29flat$204.89 million$113.84 million-2.15Earnings Announcement
News Coverage
Gap Up
NSAV
NSAV
0.3$0.02flat$129.95 millionN/A0.00News Coverage
Gap Down
Terra Tech logo
TRTC
Terra Tech
0.7$0.29flat$63.02 million$28.05 million0.00News Coverage
PVSP
Pervasip
0.4$0.01flat$45.10 millionN/A0.00Gap Up
Grow Capital logo
GRWC
Grow Capital
0.6$1.13flat$28.07 million$2.37 million0.00News Coverage
Gap Up
NMUS
Nemus Bioscience
0.6$0.12flat$16.07 millionN/A0.00High Trading Volume
Leafbuyer Technologies logo
LBUY
Leafbuyer Technologies
0.5$0.16flat$13.70 million$2.53 million0.00Gap Down
MassRoots logo
MSRT
MassRoots
0.6$0.02flat$11.16 million$20,000.000.00Gap Up
Peak Pharmaceuticals logo
PKPH
Peak Pharmaceuticals
0.7$0.14flat$10.59 millionN/A0.00News Coverage
Mentor Capital logo
MNTR
Mentor Capital
0.5$0.16flat$3.83 million$4.33 million-3.99
FutureWorld logo
FWDG
FutureWorld
0.5$0.00flat$3.80 millionN/A0.00Gap Up
DIGP
DigiPath
0.5$0.05flat$3.35 million$2.55 million-1.66Gap Up
NGBL
Notis Global
0.5$0.00flat$2.50 millionN/A0.00Gap Up
United Cannabis logo
CNAB
United Cannabis
0.4$0.02flat$1.70 millionN/A0.00
CrowdGather logo
CRWG
CrowdGather
0.7$0.01flat$1.68 million$160,000.000.00News Coverage
Gap Up
OPMZ
1PM Industries
0.4$0.00flat$0.00N/A0.00
AQSP
Acquired Sales
0.4$7.70flat$0.00N/A0.00
AMMJ
American Cannabis
0.5$0.23flat$0.00N/A0.00Gap Up
AmeriCann logo
ACAN
AmeriCann
0.4$1.21flat$0.00N/A0.00Gap Down
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.25flat$0.00N/A0.00
Cannabis Sativa logo
CBDS
Cannabis Sativa
0.5$0.78flat$0.00N/A0.00Gap Up
FRLF
Freedom Leaf
0.5$0.01flat$0.00N/A0.00Gap Up
FUTL
FutureLand
0.4$0.00flat$0.00N/A0.00News Coverage
Gap Up
GB Sciences logo
GBLX
GB Sciences
0.5$0.06flat$0.00N/A0.00News Coverage
Gap Down
GreenGro Technologies logo
GRNH
GreenGro Technologies
0.6$0.02flat$0.00N/A0.00Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$3.06flat$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01flat$0.00N/A0.00News Coverage
Gap Down
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.06flat$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Gap Up
MDCL
Medicine Man Technologies
0.5$2.22flat$0.00N/A0.00
NCAP
Northsight Capital
0.5$0.00flat$0.00N/A0.00
OWC Pharmaceutical Research logo
OWCP
OWC Pharmaceutical Research
0.6$0.01flat$0.00N/A0.00Gap Up
Surna logo
SRNA
Surna
0.6$0.07flat$0.00N/A0.00
Ultrack Systems logo
MJLB
Ultrack Systems
0.6$0.09flat$0.00N/A0.00Gap Down
BUDZ
WEED
0.6$0.59flat$0.00N/A0.00Gap Up
Zoned Properties logo
ZDPY
Zoned Properties
0.6$0.65flat$0.00N/A0.00Gap Up
ZZLL
ZZLL Information Technology
0.4$0.32flat$0.00N/A0.00High Trading Volume
Gap Down
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.